Tae-You Kim

13PUBLICATIONS
35CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersTumour immunologyInnate immunityMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 24, 2026
Heterogeneity of breast and nodal response to neoadjuvant pembrolizumab-based chemoimmunotherapy in early triple-negative breast cancer and its clinical significance.

|Sep 05, 2024
Immune microenvironmental heterogeneity according to tumor DNA methylation phenotypes in microsatellite instability-high colorectal cancers.

Jung Ho Kim, Jiyun Hong, Ji Ae Lee

|Jul 22, 2022
Intratumoral spatial heterogeneity of tumor-infiltrating lymphocytes is a significant factor for precisely stratifying prognostic immune subgroups of microsatellite instability-high colorectal carcinomas.

Minsun Jung, Ji Ae Lee, Seung-Yeon Yoo

|Jan 14, 2022
Comprehensive clinicopathologic, molecular, and immunologic characterization of colorectal carcinomas with loss of three intestinal markers, CDX2, SATB2, and KRT20.

Ji Ae Lee, Mi-Kyoung Seo, Seung-Yeon Yoo

|Dec 14, 2021
Genomic and transcriptomic characterization of heterogeneous immune subgroups of microsatellite instability-high colorectal cancers.

Jung Ho Kim, Mi-Kyoung Seo, Ji Ae Lee

|Aug 17, 2021
NTRK oncogenic fusions are exclusively associated with the serrated neoplasia pathway in the colorectum and begin to occur in sessile serrated lesions.

Jung Ho Kim, Jeong Hoon Hong, Yoon-La Choi

Pageof 3

Frequent Collaborators

7 joint publications

Kyu Joo Park

5 joint publications

Gyeong Hoon Kang

3 joint publications

Seung-Yeon Yoo

3 joint publications

Seorin Jeong